Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of January 2024, specifically dated January 12, 2024. The report details the execution of an Equity Distribution Agreement with Maxim Group LLC, enabling the company to offer and sell ordinary shares through an "at-the-market" offering mechanism under its effective Form F-3 registration statement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on the terms of a new securities distribution agreement rather than financial performance results.
Material Changes
The primary material change is the establishment of a new capital raising facility. On January 12, 2024, the company entered into an agreement allowing for the sale of ordinary shares from time to time. The company is not obligated to sell any shares under this agreement, and sales are subject to the company's instructions regarding price, time, and size limits.
Guidance, Outlook, and Risks
Management commentary is limited to the mechanics of the new agreement. Key terms include:
- Commission: The company will pay the Sales Agent a commission of 2.5% of the gross sales price per share sold.
- Expenses: The company agreed to reimburse the Sales Agent for certain specified expenses.
- Legal Opinion: A legal opinion regarding the shares is filed as Exhibit 5.1.
- Risks: The report notes that no sale of shares will occur in any jurisdiction where such an offer would be unlawful prior to registration or qualification.
Investor Verification Checklist
- Verify the terms of the Equity Distribution Agreement attached as Exhibit 10.1.
- Review the legal opinion from Sullivan & Worcester Tel Aviv (Har-Even & Co.) filed as Exhibit 5.1.
- Monitor future transaction notices to determine if and when shares are actually sold under this agreement.
- Check the company's effective Form F-3 registration statement (File No. 333-267272) for the prospectus supplement details.